ziyad al aly glp 1 GLP-1 drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden vision loss. About 6 to 10 extra cases per 10,000 users over 3 years Ziyad Al-Aly, MD (@zalaly) /

The simple solution to that problem is to consume it in smaller amounts, three times a day, so you can enhance the release of GLP-1 from the gut each time you eat

An analysis on the role of glucagonlike peptide1 receptor agonists in cognitive and mental health disorders

Since then, 503A compounding pharmacies - which operate under patient-specific prescription rules - have continued compounding semaglutide where they can document that the compounded product is not an essentially-copy of the commercially available drug, or where patient-specific clinical need exists (such as allergy to inactive ingredients or dosing requirements not available through approved products)

Additionally, tirzepatide may cause fewer gastrointestinal side effects and provides extra benefits for patients with type 2 diabetes or increased cardiovascular risk, including improved glucose control and reduced cardiovascular event risk

Immunostaining The sections were embedded in paraffin

Last reviewed: July 9, 2026 Last updated: July 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations